Category - Pharma Industry News
NHS publishes new plans to improve patient access to GP appointments
New WHO group could be ‘the last to find virus origins’
What’s trending in pharma M&A?
SMC accepts Cabometyx/Opdivo combo for advanced kidney cancer patients
Sanofi’s tolebrutinib demonstrates favourable one-year tolerability in patients with relapsing forms of multiple sclerosis
Data shows patients treated with Biogen’s MS therapies mount an effective antibody response to COVID-19 vaccination
Sanofi’s BTK inhibitor tolebrutinib shows ‘promising’ long-term MS data
MHRA backs Merck’s MET inhibitor Tepmetko